| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3441154 | American Journal of Obstetrics and Gynecology | 2008 | 7 Pages |
Abstract
Mesna, which was used at the time of cisplatin administration, protected ovaries against damage. The data that are presented challenge the existing clinical paradigm that gonadotropin-releasing hormone agonists represent the only medical method for the protection of ovaries during chemotherapy. Alternative medical means to protect ovaries during chemotherapy may be achievable.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
John MD, Beom Su PhD, Jennifer BS,